Pharmaceutical Investing Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by a Subsidiary of Roivant Sciences
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery